PULMOPHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 36428023
Bøgebjerg 2, 8400 Ebeltoft
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -8.73 | -1.06 | -80.38 | -56.50 | -47.30 |
EBIT | -8.73 | -1.06 | -80.38 | -56.50 | -47.30 |
Other financial expenses | -17.17 | -17.90 | -12.72 | -6.33 | |
Pre-tax profit | -25.91 | -18.96 | -93.10 | -62.83 | -47.30 |
Net earnings | -25.91 | -18.96 | -93.10 | -62.83 | -47.30 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Development expenditure | 52.09 | 73.51 | 882.53 | 3 965.16 | 5 173.24 |
Intangible assets total | 52.09 | 73.51 | 882.53 | 3 965.16 | 5 173.24 |
Tangible assets total | |||||
Investments total | |||||
Long term receivables total | |||||
Inventories total | |||||
Prepayments and accrued income | 1 598.01 | 887.78 | 177.56 | ||
Current other receivables | 7.42 | 5.75 | 96.38 | 81.66 | 44.38 |
Short term receivables total | 7.42 | 5.75 | 1 694.39 | 969.44 | 221.93 |
Cash and bank deposits | 20.36 | 0.36 | 1 409.60 | 18.87 | 3 501.22 |
Cash and cash equivalents | 20.36 | 0.36 | 1 409.60 | 18.87 | 3 501.22 |
Balance sheet total (assets) | 79.88 | 79.62 | 3 986.52 | 4 953.47 | 8 896.39 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 3.00 | 3.00 | 40.00 | 40.00 | 46.67 |
Share premium account | 3 963.00 | 3 963.00 | 7 956.33 | ||
Retained earnings | - 353.32 | - 379.22 | - 398.18 | - 491.29 | - 554.12 |
Profit of the financial year | -25.91 | -18.96 | -93.10 | -62.83 | -47.30 |
Shareholders equity total | - 376.22 | - 395.18 | 3 511.72 | 3 448.89 | 7 401.59 |
Non-current liabilities total | |||||
Current trade creditors | 6.50 | 7.37 | 7.37 | 14.70 | 4.92 |
Current owed to participating | 449.60 | 467.44 | 467.44 | 1 039.89 | 1 039.89 |
Other non-interest bearing current liabilities | 450.00 | 450.00 | |||
Current liabilities total | 456.10 | 474.80 | 474.80 | 1 504.58 | 1 494.80 |
Balance sheet total (liabilities) | 79.88 | 79.62 | 3 986.52 | 4 953.47 | 8 896.39 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.